The chemical substance known as "(6R,7R)-3-(5-Methyl-1,3,4-thiadiazol-2-ylsulfanyl)-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid," with the CAS number 179034-83-4, is a cephalosporin antibiotic. This compound features a cephem core structure, which is characteristic of cephalosporins, and includes a carboxylic acid functional group that contributes to its antibacterial activity. The presence of a thiadiazole moiety enhances its pharmacological properties, potentially improving its efficacy against certain bacterial strains. The phenylacetamido group is likely involved in the compound's interaction with bacterial enzymes, facilitating its mechanism of action. This antibiotic is typically used to combat a range of bacterial infections, and its stereochemistry, indicated by the (6R,7R) configuration, is crucial for its biological activity. Overall, this compound exemplifies the complexity and specificity of modern antibiotic design, aiming to target bacterial pathogens while minimizing resistance development.

(6R,7R)-3-(5-Methyl-1,3,4-thiadiazol-2-ylsulfanyl)-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid

179034-83-4: The chemical substance known as "(6R,7R)-3-(5-Methyl-1,3,4-thiadiazol-2-ylsulfanyl)-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid," with the CAS number 179034-83-4, is a cephalosporin antibiotic. This compound features a cephem core structure, which is characteristic of cephalosporins, and includes a carboxylic acid functional group that contributes to its antibacterial activity. The presence of a thiadiazole moiety enhances its pharmacological properties, potentially improving its efficacy against certain bacterial strains. The phenylacetamido group is likely involved in the compound's interaction with bacterial enzymes, facilitating its mechanism of action. This antibiotic is typically used to combat a range of bacterial infections, and its stereochemistry, indicated by the (6R,7R) configuration, is crucial for its biological activity. Overall, this compound exemplifies the complexity and specificity of modern antibiotic design, aiming to target bacterial pathogens while minimizing resistance development.

<p>FR-182024 is a novel cephem derivative, it has potent anti-Helicobacter pylori activity.</p>

CAS 179034-83-4

(6R,7R)-3-(5-Methyl-1,3,4-thiadiazol-2-ylsulfanyl)-7-(2-phenylacetamido)-3-cephem-4-carboxylic acid

FR-182024

Ref: TM-T27375